{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-085853","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2025-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.669287+00:00","generated_at":"2026-05-17T07:22:46.965618+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"60 Degrees Pharmaceuticals presents at H.C. Wainwright; no specific updates disclosed in filing","bullets":["CEO Geoff Dow scheduled to present to investors starting September 9, 2025.","Slide deck furnished to investors; filing text does not contain its substantive content.","No financial figures, guidance, or pipeline milestones provided in the 8-K.","Company is an emerging growth company listed on Nasdaq under SXTP and SXTPW."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-085853","json":"https://secwatch.observer/filing/0001213900-25-085853.json","markdown":"https://secwatch.observer/filing/0001213900-25-085853.md","text":"https://secwatch.observer/filing/0001213900-25-085853.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025085853/0001213900-25-085853-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025085853/ea0256483-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:22:46.965618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}